• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症诊断与治疗的功能化纳米材料。

Functionalized nanomaterials for diagnosis and therapy of cancer.

作者信息

Pietronave Stefano, Iafisco Michele, Locarno Deborah, Rimondini Lia, Maria Prat Maria

机构信息

Department of Medical Sciences, Università del Piemonte Orientale "A. Avogadro", Novara - Italy.

出版信息

J Appl Biomater Biomech. 2009 May-Aug;7(2):77-89.

PMID:20799167
Abstract

Recent developments in nanotechnology have provided new tools for both cancer imaging and treatment. The functionalization of the nanocarrier based drugs using biological ligands allows increasing specificity of drug targeting enhancing efficacy and reducing side effects. In this paper some current nanocarrier based drugs are described and the principles for their functionalization in cancer treatment and imaging are reviewed.

摘要

纳米技术的最新进展为癌症成像和治疗提供了新工具。使用生物配体对基于纳米载体的药物进行功能化,可以提高药物靶向的特异性,增强疗效并减少副作用。本文描述了一些当前基于纳米载体的药物,并综述了它们在癌症治疗和成像中进行功能化的原理。

相似文献

1
Functionalized nanomaterials for diagnosis and therapy of cancer.用于癌症诊断与治疗的功能化纳米材料。
J Appl Biomater Biomech. 2009 May-Aug;7(2):77-89.
2
Ligand-based targeted therapy for cancer tissue.基于配体的癌症组织靶向治疗。
Expert Opin Drug Deliv. 2009 Mar;6(3):285-304. doi: 10.1517/17425240902780166.
3
Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.用于药物存储、靶向和成像的荧光超顺磁纳米球:癌症诊断和治疗的多功能纳米载体系统。
ACS Nano. 2010 Sep 28;4(9):5398-404. doi: 10.1021/nn101000e.
4
Nanotechnology for breast cancer therapy.用于乳腺癌治疗的纳米技术。
Biomed Microdevices. 2009 Feb;11(1):49-63. doi: 10.1007/s10544-008-9209-0.
5
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
6
Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.新兴无机纳米材料在胰腺癌诊断与治疗中的应用。
Cancer Treat Rev. 2012 Oct;38(6):566-79. doi: 10.1016/j.ctrv.2012.02.003.
7
Role of nanocarrier systems in cancer nanotherapy.纳米载体系统在癌症纳米治疗中的作用。
J Liposome Res. 2009;19(4):310-21. doi: 10.3109/08982100902913204.
8
Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells.载药聚电解质微胶囊用于癌细胞的持续靶向。
Adv Drug Deliv Rev. 2011 Aug 14;63(9):847-64. doi: 10.1016/j.addr.2011.05.007. Epub 2011 May 18.
9
Medical applications of nanoparticles and nanomaterials.
Stud Health Technol Inform. 2009;149:257-83.
10
New frontiers in nanotechnology for cancer treatment.用于癌症治疗的纳米技术新前沿。
Urol Oncol. 2008 Jan-Feb;26(1):74-85. doi: 10.1016/j.urolonc.2007.03.017.

引用本文的文献

1
AC Electrokinetics of Salt-Free Multilayered Polymer-Grafted Particles.无盐多层聚合物接枝颗粒的交流电动学
Polymers (Basel). 2020 Sep 15;12(9):2097. doi: 10.3390/polym12092097.
2
Tumor Targeting by Monoclonal Antibody Functionalized Magnetic Nanoparticles.单克隆抗体功能化磁性纳米颗粒的肿瘤靶向作用
Nanomaterials (Basel). 2019 Nov 6;9(11):1575. doi: 10.3390/nano9111575.
3
Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy.抗MET/HGF受体及其配体的单克隆抗体:从基础研究到治疗应用的多功能工具
Biomedicines. 2014 Dec 3;2(4):359-383. doi: 10.3390/biomedicines2040359.
4
Evolving application of biomimetic nanostructured hydroxyapatite.仿生纳米结构羟基磷灰石的应用进展
Nanotechnol Sci Appl. 2010 Nov 9;3:107-25. doi: 10.2147/NSA.S9038.
5
Carbon nanotubes linked with pitavastatin: synthesis and characterisation.载有匹伐他汀的碳纳米管:合成与表征。
J Mater Sci Mater Med. 2011 Apr;22(4):845-51. doi: 10.1007/s10856-011-4260-4. Epub 2011 Mar 1.
6
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice.聚乙二醇-单壁碳纳米管癌症药物输送载体在小鼠体内的分布和清除。
Nanomedicine (Lond). 2010 Dec;5(10):1535-46. doi: 10.2217/nnm.10.90.